Nuvaira, Inc.

📍 Maple Grove, United States🗓 Founded 2008👥 57 employees💰 Last funded Mar 2014
Medical Device🌐 nuvaira.com
Website LinkedIn
Nuvaira, Inc. develops innovative and groundbreaking therapies that aim to improve the lives of the more than 65 million people around the world with obstructive lung disease. Founded in 2008, Nuvaira was established to address clinical needs in the treatment of overactive airway nerves, a common disease feature of both COPD and asthma. Nuvaira is a privately held medical device company, headquartered in Minneapolis, Minnesota USA and has more than 75 patents issued and pending worldwide. The dNerva® Lung Denervation System is CE Mark approved. The dNerva® lung denervation system is under clinical investigation and is not commercially available in the USA.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2008
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Nuvaira, Inc.?
Nuvaira, Inc. has 1 investors on record on gritt.io and 1 late-stage investors.
When did Nuvaira, Inc. last raise funding?
The most recent investment in Nuvaira, Inc. recorded on gritt.io was in March 2014.
When was Nuvaira, Inc. founded?
Nuvaira, Inc. was founded in 2008.
What industry is Nuvaira, Inc. in?
Nuvaira, Inc. operates in Medical Device. Find similar Medical Device investors on gritt.io.
Where is Nuvaira, Inc. based?
Nuvaira, Inc. is headquartered in Maple Grove, United States.